{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-29",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Plainsboro",
      "state": "NJ",
      "country": "United States",
      "classification": "Class I",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "88647",
      "recalling_firm": "Jacobus Pharmaceutical Company Inc.",
      "address_1": "Industrial Research Laboratory Building",
      "address_2": "31 Schalks Crossing Rd",
      "postal_code": "08536",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Product was distributed within the USA and Canada.  Control # 18038, was distributed to Canada only.",
      "recall_number": "D-0008-2022",
      "product_description": "Ruzurgi (amifampridine) Tablets 10 mg, packaged in 100-count bottles, Rx only, Manufactured by: Jacobus Pharmaceutical Company, Inc, P.O. Box 5290, Princeton, New Jersey  08540, NDC 49938-110-01.",
      "product_quantity": "2,324 bottles",
      "reason_for_recall": "Microbial contamination of non-sterile products: Firm's testing found lots to exceed specification for aerobic bacteria, yeast, and mold counts.",
      "recall_initiation_date": "20210909",
      "center_classification_date": "20211008",
      "termination_date": "20220218",
      "report_date": "20211006",
      "code_info": "Lot #: 18038, 18039, Exp 03/2023; 18079, Exp 05/2023"
    }
  ]
}